• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
  • Issues
    • Current Issue
    • Issue Archives
  • Editor's Update
  • Advertise
  • Reprints
  • Authors
    • Author Instructions
    • Submission Portal
  • Reviewers
  • Contact

Search

Volume 5 - Issue 4 - July/August 2008

Editor's Corner »

Retrievable IVC Filters: Advance or Gimmick?

By: Frank J. Criado, MD

The article by Arko et al1 served as the foundation for this editorial. The paper describes a first-in-man clinical experience (10 patients) with a new retrievable vena cava filter (VCF). The design of the Crux IVCF appears unique and quite interesting. Instead of the more standard conical, strut-and-hook designs we have all seen many times in the past, this new device features a symmetrical double-loop helical construct. It is meant to be self-centering within the lumen of the vena cava and provide “consistent clot trapping over the entire inferior vena cava (IVC) circumference

Read the full story »

Original Contribution »

Early Clinical Experience with a Novel, Self-Centering, Bi-Directional Vena Cava Filter

By: Frank Arko, III, MD, Erin Murphy, MD, Charles M. Davis, III, David Rosenthal, MD, Adrian Ebner, MD, Thomas Fogarty, MD

Introduction
Pulmonary emboli (PE) are estimated to be the third leading cause of cardiovascular death in the United States. Over 600,000 cases are reported in the US annually, causing an estimated 120,000 to 150,000 deaths per year. Emboli most commonly arise from pre-existing deep venous thromboses (DVT). While anticoagulation remains the gold standard of care for both DVT and PE, many patients are contraindicated for anticoagulation1 and up to one-third of PE occurs in patients already on anticoagulant therapy.

Caval interruption by placement of an inferior vena cava

Read the full story »

Clinical Decision Making »

Endovascular Treatment of a Long-Segment Iliac Artery Occlusion with a Stent Extending up to the Hip Joint

By: George Koshy Chiramel, DMRD, MD, Shyamkumar N. Keshava, DNB, FRCR, FRANZCR, Thomas Mammen, MD, Vinu Moses, MD, Edwin Stephen, MS, Sunil Agarwal, MS

Aortofemoral bypass graft surgery is the treatment of choice for severe symptomatic aortoiliac occlusive disease.1 An endovascular procedure may be preferred in patients who are at high risk for a major surgery under general anesthesia. We describe such a situation that required the deployment of a stent with its distal end extending up to the hip joint line in order to achieve optimal positioning. For this purpose, a special stent with adequate axial flexibility and tensile strength was chosen to prevent kinking during joint movement.

Case Report
A 60-year-old man p

Read the full story »

Case Study »

Unusual Life-Threatening Complications of a Ruptured Infrarenal Aortic Aneurysm in a Young Adult

By: 1Kumaran Chinnappan, MD, 1Archana Abhyankar, MD, 2Zafar Jameel, MD, John Cosgrove, MD

Case Report
A 34-year-old man presented with a ruptured infrarenal abdominal aortic aneurysm (AAA) (Figure 1). He reported no previous symptoms or illness. His father died at the age of 46 years from a drug overdose. His mother died of AIDS at the age of 44 years. The patient underwent emergency repair of the AAA with a Dacron tube graft and had a smooth postoperative recovery. However, he was readmitted 18 months later with severe abdominal pains. A computed tomography (CT) scan and magnetic resonance angiogram of the aorta indicated a false aneurysm of the distal aortic suture line

Read the full story »

Case Study »

Autotransplant and Renal Artery Aneurysm Repair in a Patient with a Congenital Solitary Kidney

By: Mary Ann Lim, MD, Ami Patel, MD, Edward Woo, MD, Debbie Cohen, MD

Case Report. A 44-year-old, normotensive woman with a 28-pack year history of smoking and a congenital solitary kidney was referred for a right renal artery aneurysm (RAA) seen on magnetic resonance imaging (MRI). The MRI was done as part of a work up for back pain 2 years previously. The patient subsequently had a computed tomography (CT) angiogram where a 2-cm aneurysm was seen in the right renal artery at the hilum of the kidney, with 5 of 7 branches of the renal artery arising from the aneurysm, excluding endovascular repair. The patient initially opted for watchful observation.

Read the full story »

Case Study and Review »

Giant Splenic Artery Aneurysm

By: Muhammad Asad, MD, FRCS, Mahalingam Sivakumar, MD, FRCS, FACS

Introduction
Splenic artery aneurysm (SAA) is an infrequent occurrence, but it is important to evaluate the size and the location of the aneurysm to prevent life-threatening complications. SAA is more common in women than in men. Pregnancy is a major risk factor for rupture. The patient presented here had a very poor general condition, with acute pancreatitis and other severe comorbid conditions. There was a high risk of SAA rupture, owing to the huge size. Angioembolization of SAA was performed successfully with metallic coils. Endovascular procedures are currently the first choice of

Read the full story »

  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Tara Fields, Classified Sales Manager
    (800) 237-7285, ext. 259

vdm Blogs

EVAR found superior to open AAA repair for long-term survival in Medicare patients: Another nail in open surgery’s coffin?

Frank J Criado MD FACS FSVM

Aneurysms and Cancer: Which comes first in the endovascular era?

Ross Milner MD FACS

What is the best therapy when we compare current data for revascularization of the SFA?

Lawrence A. Garcia MD

When a Patient Presents with an Ulcer, Take a Careful History

Richard R. Heuser MD FACC FACP FESC FSCAI

Long-term results with bare-metal LifeStent in the SFA: Is this bad news for DES technologies?

Frank J Criado MD FACS FSVM
more »

Vascular Newswire

  • PROMUS Element Stent Demonstrates Excellent Long-Term Safety and Effectiveness in PLATINUM Small Vessel Study
    Mon, 05/21/12 - 9:50am
  • Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe
    Thu, 05/17/12 - 10:22am
  • Abbott's XIENCE PRIME and XIENCE V Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy
    Wed, 05/16/12 - 9:26am
  • Hospital Mortality Rates for Cardiovascular Revascularization Patients Varies Significantly by State
    Tue, 05/15/12 - 9:31am
more »

Clinical Events Calendar

  • International Vein Congress (IVC) 2012
    Thu, 05/31/2012 - Sun, 06/03/2012
    Miami Beach, FL, United States
  • New Cardiovascular Horizons (NCVH)
    Wed, 06/06/2012 - Sat, 06/09/2012
    New Orleans, LA, United States
  • Peripheral Vascular Surgery Society Annual Spring Meeting
    Thu, 06/07/2012 - Sat, 06/09/2012
    National Harbor, MD, United States
more »

Poll

The current focus to decrease the profile size of aortic stent-grafts: :
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2012 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2012 HMP Communications